Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial

Open access
Sonabend, Adam M, Gould, Andrew, Amidei, Christina, Ward, Rachel, Schmidt, Karyn A, Zhang, Daniel Y, Gomez, Cristal, Bebawy, John F, Liu, Benjamin P, Bouchoux, Guillaume, Desseaux, Carole, Helenowski, Irene B, Lukas, Rimas V, Dixit, Karan, Kumthekar, Priya, Arrieta, Víctor A, Lesniak, Maciej S, Carpentier, Alexandre, Zhang, Hui, Muzzio, Miguel, Canney, Michael, Stupp, Roger · 2023 · The Lancet Oncology

Abstract

Background: Low-intensity pulsed ultrasound with microbubbles (LIPU/MB) can be used to open the blood-brain barrier (BBB). We aimed to determine the safety and pharmacokinetics of LIPU/MB to enhance the delivery of albumin-bound paclitaxel (ABX) to the peri-tumoral brain of recurrent glioblastoma (GBM) patients. Methods: We conducted a dose-escalation phase 1 clinical trial (NCT04528680). Adults (>18 years old) with recurrent GBM, tumor diameter <70 mm, and Karnofsky-performance ≥70 were eligible. A nine-emitter ultrasound device was implanted into a skull-window after tumor resection. LIPU/MB with intravenous ABX infusion was performed every 3 weeks for up to 6 cycles. Six dose levels (40-260 mg/m2) were evaluated. We did pharmacokinetic analyses of LIPU/MB in a subgroup of patients from the current study, and a subgroup who received carboplatin as part of a similar trial (NCT03744026). The primary endpoint was dose-limiting toxicity (DLT). Safety was assessed in all treated patients (n=17). Analysis was performed as per protocol. BBB opening was investigated by pre and post-sonication MRI. Findings: 9 males and 8 females were enrolled between October 29th 2020 and February 21st 2022. Median follow-up was 11.89 months (IQR 11.12, 12.78). At a dose level of 260 mg/m2, grade 3 encephalopathy occurred in 1/12 patients (8%) during the first cycle (considered DLT), and on a second patient on cycle 2 (grade 2). In both cases, it resolved, and treatment continued at a lower ABX dose. Imaging analysis showed BBB opening in the brain regions targeted by LIPU/MB which diminished over the first 1 hr. after sonication. LIPU/MB led to increase in brain parenchymal concentrations of ABX by 3.7-times (non-sonicated brain mean [ABX] 0.0373 uM, 95% CI 0.0223 - 0.0625 uM vs. sonicated brain mean [ABX] 0.1386 uM, 95% CI 0.0828 – 0.2319 uM, p<0.0001) and of carboplatin by 5.9-times (non-sonicated brain mean [carboplatin] 0.9914 uM, 95% CI 0.5624 - 1.747 uM vs. sonicated brain mean [carboplatin] 5.878 uM, 95% CI 3.4622 - 9.98 uM, p=0.00012 on pharmacokinetic study done on a similar trial (NCT03744026). Interpretations: LIPU/MB using a skull-implantable ultrasound transiently opens the BBB allowing for safe, repeated penetration of cytotoxic drugs into the brain. This study has prompted a subsequent phase 2 study, which is ongoing. Funding: NIH/NCI 1R01CA245969-01A1, P50CA221747, and philanthropic support. In-kind support from Carthera and BMS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(23)00112-2

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 260

Metadata

Authors
Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., Gomez, C., Bebawy, J. F., Liu, B. P., Bouchoux, G., Desseaux, C., Helenowski, I. B., Lukas, R. V., Dixit, K., Kumthekar, P., Arrieta, V. A., Lesniak, M. S., Carpentier, A., Zhang, H., Muzzio, M., Canney, M., & Stupp, R.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2023-05
Volume
24
Issue
5
Pages
509-522
ISSN
1470-2045 (ISSN-L)
OpenAlex
W4367673693
Cited by
260
References
28
FWCI
19.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. https://app.cochat.ai/papers/10.1016/s1470-2045(23)00112-2
The paper
Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., Gomez, C., Bebawy, J. F., Liu, B. P., Bouchoux, G., Desseaux, C., Helenowski, I. B., Lukas, R. V., Dixit, K., Kumthekar, P., Arrieta, V. A., Lesniak, M. S., Carpentier, A., Zhang, H., . . . Stupp, R. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(23)00112-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.